Juan Du

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 25

Top Topics

Stem Cell Transplantation

Acute Lymphoblastic Leukemia

Multiple Myeloma

Ulcerative Colitis

Top Venues

Bone marrow transplantation

Clinical and experimental immunology

Cancer medicine

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Xiaoli Hu, Xinyi Zhou, Qian Zhao, Ying Yang, Zhi-Wei Liang, Yuchen Xiao, Zhuoqun Liu, Liu Liu, Chao Zhang, Juan Du
Metformin augments GPRC5D in multiple myeloma and enhances the efficacy of GPRC5D-CAR T cells. British journal of haematology (2024)
Pei Guo, Yun Wang, Haiyan He, Dongjian Chen, Jin Liu, Wanting Qiang, Jing Lu, Yang Liang, Juan Du
Elevated serum levels of soluble B-cell maturation antigen as a prognostic biomarker for multiple myeloma. Clinical and experimental immunology (2024)
Haiyan He, Nan Hou, Xi Chen, Yaqi Song, Wanting Qiang, Jin Liu, Jing Lu, Weijun Fu, Juan Du
An open-label, prospective trial to evaluate the efficacy and safety of ixazomib in combination with cyclophosphamide and dexamethasone in patients with newly diagnosed POEMS syndrome. British journal of haematology 205 (2) (2024)
Pei Guo, Yun Wang, Haiyan He, Dongjian Chen, Jin Liu, Wanting Qiang, Jing Lu, Yang Liang, Juan Du
Elevated serum levels of soluble B-cell maturation antigen as a prognostic biomarker for multiple myeloma. Clinical and experimental immunology 217 (3) (2024)
Pei Guo, Yun Wang, Haiyan He, Dongjian Chen, Jin Liu, Wanting Qiang, Jing Lu, Yang Liang, Juan Du
Elevated serum levels of soluble B-cell maturation antigen as a prognostic biomarker for multiple myeloma. Clinical and experimental immunology 217 (3) (2024)
Haiyan He, Nan Hou, Xi Chen, Yaqi Song, Wanting Qiang, Jin Liu, Jing Lu, Weijun Fu, Juan Du
An open-label, prospective trial to evaluate the efficacy and safety of ixazomib in combination with cyclophosphamide and dexamethasone in patients with newly diagnosed POEMS syndrome. British journal of haematology (2024)
Dongjian Chen, Yu Zhu, Zhi Cheng, Songfu Jiang, Haiyan He, Wan-Ting Qiang, Fang Xiang, Xuedong Sun, Juan Du
A five-year follow-up clinical study of the B cell maturation antigen chimeric antigen receptor-T cell therapy HDS269B in patients with relapsed or refractory multiple myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Pei Guo, Yun Wang, Haiyan He, Dongjian Chen, Jin Liu, Wanting Qiang, Jing Lu, Yang Liang, Juan Du
Elevated serum levels of soluble B-cell maturation antigen as a prognostic biomarker for multiple myeloma. Clinical and experimental immunology 217 (3) (2024)
Dongjian Chen, Yu Zhu, Zhi Cheng, Songfu Jiang, Haiyan He, Wan-Ting Qiang, Fang Xiang, Xuedong Sun, Juan Du
A 5-Year Follow-up Clinical Study of the B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy HDS269B in Patients with Relapsed or Refractory Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (17) (2024)
Huixing Zhou, Yuan Jian, Juan Du, Junru Liu, Zhi-Yao Zhang, Guangzhong Yang, Guorong Wang, Ying Tian, Yanchen Li, Yin Wu, Wenming Chen, Weijun Fu, Juan Li, Wen Gao
Prognostic nomogram for multiple myeloma early relapse after autologous stem cell transplant in the novel agent era. Cancer medicine (2023)
Wanting Qiang, Lina Jin, Tiancheng Luo, Yanchun Jia, Jing Lu, Jin Liu, Haiyan He, Ziliang Qian, Sridurga Mithraprabhu, Zhi-Wei Liang, Robert Peter Gale, Xia Tao, Depei Wu, Juan Du
Cell-free DNA chromosome copy number variations predict outcomes in plasma cell myeloma. Blood cancer journal 13 (1) (2023)
Jin Liu, Jing Lu, Wanting Qiang, Yanchun Jia, Haiyan He, Xiaofei Ye, Wee-Joo Chng, Robert Peter Gale, Zhi-Wei Liang, Jian Hou, Juan Du
Sensitive quantitative IgD assay increases progression-free survival prediction accuracy in IgD plasma cell myeloma. Leukemia (2022)
Weiping Liu, Jie Ji, Dehui Zou, Yang Cao, Yajing Xu, Jian Zhou, Sujun Gao, Fengrong Wang, Wenming Chen, Juan Du, Hui Zhou, Fuling Zhou, Jimin Shi, Xi Zhang, Jianmin Yang, Hongmei Jing, Zhongxing Jiang, Hui Liu, Caixia Li, Hongling Peng, Songfu Jiang, Xiaolei Wei, Pengcheng He, Yao Liu, Haiyan Yang, Zengjun Li, Xiaobing Huang, Lin Liu, Lijing Shen, Chuanfang Liu, Yu-Qin Song, Lugui Qiu, Xiaopei Wang, Jun Ma, Jun Zhu
Autologous hematopoietic stem cell transplantation activity for lymphoma and multiple myeloma in China. Bone marrow transplantation 58 (3) (2022)
Xinyi Zhou, Juan Du
CircRNAs: novel therapeutic targets in multiple myeloma. Molecular biology reports 49 (11) (2022)
Haiyan He, Zifeng Li, Jing Lu, Wanting Qiang, Sihan Jiang, Yaochen Xu, Weijun Fu, Xiaowen Zhai, Lin Zhou, Maoxiang Qian, Juan Du
Single-cell RNA-seq reveals clonal diversity and prognostic genes of relapsed multiple myeloma. Clinical and translational medicine 12 (3) (2022)
Weiping Liu, Jie Ji, Dehui Zou, Yang Cao, Yajing Xu, Jian Zhou, Sujun Gao, Fengrong Wang, Wenming Chen, Juan Du, Hui Zhou, Fuling Zhou, Jimin Shi, Xi Zhang, Jianmin Yang, Hongmei Jing, Zhongxing Jiang, Hui Liu, Caixia Li, Hongling Peng, Songfu Jiang, Xiaolei Wei, Pengcheng He, Yao Liu, Haiyan Yang, Zengjun Li, Xiaobing Huang, Lin Liu, Lijing Shen, Chuanfang Liu, Yu-Qin Song, Lugui Qiu, Xiaopei Wang, Jun Ma, Jun Zhu
Autologous hematopoietic stem cell transplantation activity for lymphoma and multiple myeloma in China. Bone marrow transplantation 58 (3) (2022)
Weiping Liu, Jie Ji, Dehui Zou, Yang Cao, Yajing Xu, Jian Zhou, Sujun Gao, Fengrong Wang, Wenming Chen, Juan Du, Hui Zhou, Fuling Zhou, Jimin Shi, Xi Zhang, Jianmin Yang, Hongmei Jing, Zhongxing Jiang, Hui Liu, Caixia Li, Hongling Peng, Songfu Jiang, Xiaolei Wei, Pengcheng He, Yao Liu, Haiyan Yang, Zengjun Li, Xiaobing Huang, Lin Liu, Lijing Shen, Chuanfang Liu, Yu-Qin Song, Lugui Qiu, Xiaopei Wang, Jun Ma, Jun Zhu
Autologous hematopoietic stem cell transplantation activity for lymphoma and multiple myeloma in China. Bone marrow transplantation (2022)
Dongjian Chen, Xiaoxiang Wang, Zhi Cheng, Songfu Jiang, Hua Jiang, Weijun Fu, Fang Xiang, Xuedong Sun, Juan Du
Subsequent anti-myeloma therapy after maturation antigen (BCMA) chimeric antigen receptor (CAR)-T cell (HDS269B) treatment in patients with relapsed/refractory multiple myeloma. American journal of hematology 97 (12) (2022)
Weiping Liu, Jie Ji, Dehui Zou, Yang Cao, Yajing Xu, Jian Zhou, Sujun Gao, Fengrong Wang, Wenming Chen, Juan Du, Hui Zhou, Fuling Zhou, Jimin Shi, Xi Zhang, Jianmin Yang, Hongmei Jing, Zhongxing Jiang, Hui Liu, Caixia Li, Hongling Peng, Songfu Jiang, Xiaolei Wei, Pengcheng He, Yao Liu, Haiyan Yang, Zengjun Li, Xiaobing Huang, Lin Liu, Lijing Shen, Chuanfang Liu, Yu-Qin Song, Lugui Qiu, Xiaopei Wang, Jun Ma, Jun Zhu
Autologous hematopoietic stem cell transplantation activity for lymphoma and multiple myeloma in China. Bone marrow transplantation 58 (3) (2022)
Juan Du, Runhong Wei, Songfu Jiang, Hua Jiang, Lu Li, Wanting Qiang, Haiyan He, Lin Shi, Qiuling Ma, Kang Yu, Xiaoyuan Zhang, Hanyi Ding, Xuedong Sun, Fang Xiang, Lin Zhu, Zhi Cheng, Weijun Fu
CAR-T cell therapy targeting B cell maturation antigen is effective for relapsed/refractory multiple myeloma, including cases with poor performance status. American journal of hematology 97 (7) (2022)
Zhiyu Liang, Ping Li, Liqing Kang, Lili Zhou, Yang Xu, Shiguang Ye, Juan Du, Bing Li, Yiwen Wang, Lei Yu, Wenbin Qian, Aibin Liang
Immunoglobulin Isotype Switch after Anti-BCMA CAR T-Cell Therapy for Relapsed or Refractory Multiple Myeloma. Blood advances (2021)
Jie-Jing Qian, Xiaoxia Hu, Ying Wang, Yi Zhang, Juan Du, Min Yang, Hongyan Tong, Wen-Bin Qian, Juying Wei, Wenjun Yu, Yin-Jun Lou, Liping Mao, Hai Tao Meng, Liang-Shun You, Libing Wang, Xia Li, Xin Huang, Li-Hong Cao, Jian-Zhi Zhao, Xiao Yan Yan, Yu-Bao Chen, Yu Chen, Su-Jiang Zhang, Jie Jin, Jiong Hu, Hong Hu Zhu
CAG regimen for refractory or relapsed adult T-cell acute lymphoblastic leukemia: A retrospective, multicenter, cohort study. Cancer medicine 9 (15) (2020)
Juan Du, Jing Lu, Wen Gao, Jin Liu, Haiyan He, Lu Li, Rong Li, Lili Zhou, Hua Jiang, Wenming Chen, Weijun Fu, Jian Hou
Serum-free light chains combined with the Revised International Staging System could further distinguish the superior and inferior clinical outcome of multiple myeloma patients. Annals of hematology 99 (8) (2020)
Jin Liu, Xiaoxia Hu, Yanchun Jia, Jin Lu, Jae Hoon Lee, Kihyun Kim, Wenming Chen, Aijun Liu, Yang Liu, Qi Chen, Chunyang Zhang, Cheolwon Suh, Min Kyoung Kim, Fan Zhou, Wee Joo Chng, Shaji K Kumar, Brian Durie, Jian Hou, Weijun Fu, Juan Du
Clinical features and survival outcomes in IgD myeloma: a study by Asia Myeloma Network (AMN). Leukemia 35 (6) (2020)
Wen Gao, Yuan Jian, Juan Du, Xiaozhe Li, Huixing Zhou, Zhi-Yao Zhang, Guangzhong Yang, Guorong Wang, Ying Tian, Yanchen Li, Yin Wu, Weijun Fu, Juan Li, Wenming Chen
Gain of 1q21 is an adverse prognostic factor for multiple myeloma patients treated by autologous stem cell transplantation: A multicenter study in China. Cancer medicine 9 (21) (2020)